149 related articles for article (PubMed ID: 10506452)
1. Severe hemolytic reaction due to anti-JK3.
Marshall CS; Dwyre D; Eckert R; Russell L
Arch Pathol Lab Med; 1999 Oct; 123(10):949-51. PubMed ID: 10506452
[TBL] [Abstract][Full Text] [Related]
2. Notorious anti-Jk3 in a pregnant woman.
Jator EK
Clin Lab Sci; 2014; 27(2):78-82. PubMed ID: 25000650
[TBL] [Abstract][Full Text] [Related]
3. Temporary suppression of Kidd system antigen expression accompanied by transient production of anti-Jk3.
Issitt PD; Obarski G; Hartnett PL; Wren MR; Prewitt PL
Transfusion; 1990 Jan; 30(1):46-50. PubMed ID: 2296791
[TBL] [Abstract][Full Text] [Related]
4. The Kidd (JK) Blood Group System.
Lawicki S; Covin RB; Powers AA
Transfus Med Rev; 2017 Jul; 31(3):165-172. PubMed ID: 28065763
[TBL] [Abstract][Full Text] [Related]
5. Donor anti-Jk(a) causing hemolysis in a liver transplant recipient.
Hareuveni M; Merchav H; Austerlitz N; Rahimi-Levene N; Ben-Tal O
Transfusion; 2002 Mar; 42(3):363-7. PubMed ID: 11961243
[TBL] [Abstract][Full Text] [Related]
6. The Jk(a-b-) phenotype in New Zealand Polynesians.
Woodfield DG; Douglas R; Smith J; Simpson A; Pinder L; Staveley JM
Transfusion; 1982; 22(4):276-8. PubMed ID: 7101419
[TBL] [Abstract][Full Text] [Related]
7. Jk3 alloantibodies during pregnancy-blood bank management and hemolytic disease of the fetus and newborn risk.
Lawicki S; Coberly EA; Lee LA; Johnson M; Eichbaum Q
Transfusion; 2018 May; 58(5):1157-1162. PubMed ID: 29479723
[TBL] [Abstract][Full Text] [Related]
8. A case series highlighting a common approach to identifying anti-Jk3.
Talabong DJAM; Kelley WE
Immunohematology; 2021 Jun; 37(2):84-88. PubMed ID: 34170639
[TBL] [Abstract][Full Text] [Related]
9. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
[TBL] [Abstract][Full Text] [Related]
10. Production of human monoclonal anti-Jk3, recognising an epitope including the Jk(a) /Jk(b) polymorphic site of the Kidd glycoprotein.
Toyoda C; Suzuki Y; Tsuneyama H; Onodera T; Masuno A; Yabe R; Ogasawara K; Okuda M; Nakajima K; Uchikawa M
Transfus Med; 2014 Oct; 24(5):286-91. PubMed ID: 25180691
[TBL] [Abstract][Full Text] [Related]
11. Anti-Jk
Kay B; Poisson JL; Tuma CW; Shulman IA
Transfusion; 2016 Dec; 56(12):2973-2979. PubMed ID: 27596036
[TBL] [Abstract][Full Text] [Related]
12. Possible insensitivity of the polybrene antibody screen to detect anti-Jka.
Liu F; Liu J
Ann Clin Lab Sci; 2006; 36(1):101-2. PubMed ID: 16501244
[TBL] [Abstract][Full Text] [Related]
13. Delayed hemolytic transfusion reaction due to anti-Jk(a).
Vucelic D; Savic N; Djordjevic R
Acta Chir Iugosl; 2005; 52(3):111-5. PubMed ID: 16813007
[TBL] [Abstract][Full Text] [Related]
14. [A delayed hemolytic transfusion reaction due to irregular antibodies with an anti-Kidd(a) specificity].
Mörsdorf S; Fritsch E; Wagner B; Seyfert UT; Wenzel E
Dtsch Med Wochenschr; 1997 Oct; 122(43):1313-6. PubMed ID: 9410695
[TBL] [Abstract][Full Text] [Related]
15. Development of anti-Jk3 associated with silenced Kidd antigen expression and a novel single nucleotide variant of the
Manrai PA; Siddon AJ; Hager KM; Hendrickson JE; Keller MA; Tormey CA
Immunohematology; 2021 Sep; 37(3):109-112. PubMed ID: 34591379
[TBL] [Abstract][Full Text] [Related]
16. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation.
Leo A; Mytilineos J; Voso MT; Weber-Nordt R; Liebisch P; Lensing C; Schraven B
Transfusion; 2000 Jun; 40(6):632-6. PubMed ID: 10864980
[TBL] [Abstract][Full Text] [Related]
17. Anti-Jkb delayed hemolytic transfusion reaction after coronary bypass surgery.
Shahian DM; Weiner NJ; Kurtz SR
Panminerva Med; 1995 Jun; 37(2):95-7. PubMed ID: 8637777
[TBL] [Abstract][Full Text] [Related]
18. Mild hemolytic disease of the newborn due to anti-Jk3: a serologic study of the family's Kidd antigens.
Kuczmarski CA; Bergren MO; Perkins HA
Vox Sang; 1982; 43(6):340-4. PubMed ID: 7179859
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms responsible for delayed and immediate hemolytic transfusion reactions in a patient with anti-E + Jk(b)+ Di(b) and anti-HLA alloantibodies.
Okamoto T; Hashimoto M; Samejima H; Mori A; Wakabayashi M; Takeda A; Nakamura H; Naruse H; Bouike Y; Araki N
Immunopharmacol Immunotoxicol; 2004; 26(4):645-52. PubMed ID: 15658612
[TBL] [Abstract][Full Text] [Related]
20. Anti-Jka, -C, and -E in a single patient, initially demonstrable only by the manual hexadimethrine bromide (Polybrene) test, with incompatibilities confirmed by 51Cr-labeled red cell studies.
Maynard BA; Smith DS; Farrar RP; Kraetsch RE; Chaplin H
Transfusion; 1988; 28(4):302-6. PubMed ID: 3133842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]